EMA — authorised 13 January 2020
- Marketing authorisation holder: Novartis Europharm Limited
- Status: approved
🇪🇺 Mayzent in European Union
EMA authorised Mayzent on 13 January 2020
Marketing authorisation
Mayzent in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in European Union
Frequently asked questions
Is Mayzent approved in European Union?
Yes. EMA authorised it on 13 January 2020.
Who is the marketing authorisation holder for Mayzent in European Union?
Novartis Europharm Limited holds the EU marketing authorisation.